speb/financial-data huggingface dataset:
DuPont ROE decomposition for CRI (quarterly period ending 2025-12-31)
ROE: 7.17643837759612%
Net margin: 6.939103204815813%
Asset turnover: 0.3676137940129603
Equity multiplier (leverage): 2.813285541071359
EBIT margin: 9.151538006874487%
Interest burden factor: 0.8967447132584747
Tax burden factor: 0.8455522199399589
ROE archetype: Standard Business
DuPont ROE decomposition for CRI (quarterly period ending 2026-03-31)
ROE: 1.5469070760532073%
Net margin: 2.104790247726882%
Asset turnover: 0.2697677550313142
Equity multiplier (leverage): 2.724365458954791
EBIT margin: 4.175959055252212%
Interest burden factor: 0.698097950286538
Tax burden factor: 0.7219983883964545
ROE archetype: Low Return
DuPont ROE decomposition for CRIN.DE (annual period ending 2022-12-31)
ROE: 10.194182402318221%
Net margin: 30.769596425345817%
Asset turnover: 0.024525136603740148
Equity multiplier (leverage): 13.508874435012679
Tax burden factor: 0.8880504870352587
ROE archetype: Standard Business
DuPont ROE decomposition for CRIN.DE (annual period ending 2023-12-31)
ROE: 15.249764071722199%
Net margin: 37.594637223974765%
Asset turnover: 0.0315767319128917
Equity multiplier (leverage): 12.846062967070779
Tax burden factor: 0.8325910400838354
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CRIN.DE (annual period ending 2024-12-31)
ROE: 14.880464531137482%
Net margin: 36.773392527935584%
Asset turnover: 0.03278707533712254
Equity multiplier (leverage): 12.3418457114757
Tax burden factor: 0.7600311041990668
ROE archetype: Standard Business
DuPont ROE decomposition for CRIN.DE (annual period ending 2025-12-31)
ROE: 17.743914557208953%
Net margin: 43.84759774751388%
Asset turnover: 0.032010826671225005
Equity multiplier (leverage): 12.641736761664548
Tax burden factor: 0.8091237379320511
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CRLA.PA (annual period ending 2021-12-31)
ROE: 4.490700028031625%
Net margin: 34.71596003011296%
Asset turnover: 0.01821263920477435
Equity multiplier (leverage): 7.102512094051064
Tax burden factor: 0.7521555918014982
ROE archetype: Low Return
DuPont ROE decomposition for CRLA.PA (annual period ending 2022-12-31)
ROE: 4.4543779325373825%
Net margin: 35.33892257428723%
Asset turnover: 0.017036586341551488
Equity multiplier (leverage): 7.398627783433115
Tax burden factor: 0.8072039771572197
ROE archetype: Low Return
DuPont ROE decomposition for CRLA.PA (annual period ending 2023-12-31)
ROE: 3.675595043420387%
Net margin: 30.35468174757781%
Asset turnover: 0.01662755733324078
Equity multiplier (leverage): 7.282383057237657
Tax burden factor: 0.8438518391281735
ROE archetype: Low Return
DuPont ROE decomposition for CRLA.PA (annual period ending 2025-12-31)
ROE: 3.1307481623629005%
Net margin: 31.89922734911607%
Asset turnover: 0.016380673281723594
Equity multiplier (leverage): 5.99150908553274
Tax burden factor: 0.8124143131340829
ROE archetype: Low Return
DuPont ROE decomposition for CRMD (quarterly period ending 2025-03-31)
ROE: 17.968796893476682%
Net margin: 52.82227112225577%
Asset turnover: 0.26127341434507234
Equity multiplier (leverage): 1.301987183209867
EBIT margin: 51.494294048411035%
Interest burden factor: 1.0257888198757763
Tax burden factor: 1
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CRMD (quarterly period ending 2025-06-30)
ROE: 11.819316467255499%
Net margin: 49.89829576067921%
Asset turnover: 0.19760607358458518
Equity multiplier (leverage): 1.198688557121195
EBIT margin: 49.18239495439868%
Interest burden factor: 1.0412404530303034
Tax burden factor: 0.9743724756121628
ROE archetype: Standard Business
DuPont ROE decomposition for CRMD (quarterly period ending 2025-09-30)
ROE: 36.50650826913186%
Net margin: 104.11189558055311%
Asset turnover: 0.20783136074181274
Equity multiplier (leverage): 1.6871700646953667
EBIT margin: 49.240780334830816%
Interest burden factor: 1.0239592726719757
Tax burden factor: 2.0648701394764752
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CRMD (quarterly period ending 2025-12-31)
ROE: 3.5975073507151527%
Net margin: 10.900837555330913%
Asset turnover: 0.1631134817319661
Equity multiplier (leverage): 2.0232612511558767
EBIT margin: 45.97140818371294%
Interest burden factor: 0.9546764408254013
Tax burden factor: 0.24837956111170598
ROE archetype: Low Return
DuPont ROE decomposition for CRMD (quarterly period ending 2026-03-31)
ROE: 9.165008618683787%
Net margin: 30.292638137914256%
Asset turnover: 0.15523039337206773
Equity multiplier (leverage): 1.9490322381510905
EBIT margin: 49.95644565123561%
Interest burden factor: 0.8741242263344748
Tax burden factor: 0.693701141162728
ROE archetype: Standard Business
DuPont ROE decomposition for CRML (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 1.9878129288987267
ROE archetype: Standard Business
DuPont ROE decomposition for CRML (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 1.8577563752643804
ROE archetype: Standard Business
DuPont ROE decomposition for CRON (annual period ending 2022-12-31)
ROE: -14.78872251885248%
Net margin: -154.37553178836424%
Asset turnover: 0.09010732814018692
Equity multiplier (leverage): 1.06314397299126
EBIT margin: -95.50690295605712%
ROE archetype: Low Return
DuPont ROE decomposition for CRON (annual period ending 2023-12-31)
ROE: -6.713136839724619%
Net margin: -61.49746403924503%
Asset turnover: 0.10378847950618655
Equity multiplier (leverage): 1.051766037780979
EBIT margin: -66.4421717801613%
ROE archetype: Low Return
DuPont ROE decomposition for CRON (annual period ending 2024-12-31)
ROE: 3.574583389470207%
Net margin: 25.38607473690065%
Asset turnover: 0.13476098331938546
Equity multiplier (leverage): 1.044878294050091
EBIT margin: -36.799302933488235%
Tax burden factor: 1.1228338708795715
ROE archetype: Low Return
DuPont ROE decomposition for CRON (annual period ending 2025-12-31)
ROE: -0.26538893740166386%
Net margin: -1.5147675615293514%
Asset turnover: 0.16708721306856772
Equity multiplier (leverage): 1.0485607669825008
EBIT margin: -10.083107936885547%
ROE archetype: Low Return
DuPont ROE decomposition for CRON.TO (annual period ending 2022-12-31)
ROE: -14.78872251885248%
Net margin: -154.37553178836424%
Asset turnover: 0.09010732814018692
Equity multiplier (leverage): 1.06314397299126
EBIT margin: -95.50690295605712%
ROE archetype: Low Return
DuPont ROE decomposition for CRON.TO (annual period ending 2023-12-31)
ROE: -6.713136839724619%
Net margin: -61.49746403924503%
Asset turnover: 0.10378847950618655
Equity multiplier (leverage): 1.051766037780979
EBIT margin: -66.4421717801613%
ROE archetype: Low Return
DuPont ROE decomposition for CRON.TO (annual period ending 2024-12-31)
ROE: 3.574583389470207%
Net margin: 25.38607473690065%
Asset turnover: 0.13476098331938546
Equity multiplier (leverage): 1.044878294050091
EBIT margin: -36.799302933488235%
Tax burden factor: 1.1228338708795715
ROE archetype: Low Return
DuPont ROE decomposition for CRON.TO (annual period ending 2025-12-31)
ROE: -0.26538893740166386%
Net margin: -1.5147675615293514%
Asset turnover: 0.16708721306856772
Equity multiplier (leverage): 1.0485607669825008
EBIT margin: -10.083107936885547%
ROE archetype: Low Return
DuPont ROE decomposition for CRRX.TO (quarterly period ending 2024-12-31)
ROE: -2.665384432730209%
Net margin: -2.4354259554571986%
Asset turnover: 0.412372840411921
Equity multiplier (leverage): 2.653963052666572
EBIT margin: 0.5001030581139281%
Interest burden factor: -4.800433839479393
ROE archetype: Low Return
DuPont ROE decomposition for CRRX.TO (quarterly period ending 2025-03-31)
ROE: 0.26607746722382747%
Net margin: 0.25348967057509775%
Asset turnover: 0.4006254319976916
Equity multiplier (leverage): 2.620048409688971
EBIT margin: 2.902289223897264%
Interest burden factor: 0.08734128510965757
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for CRRX.TO (quarterly period ending 2025-06-30)
ROE: 0.6610893697681424%
Net margin: 0.613852719115877%
Asset turnover: 0.422666630293001
Equity multiplier (leverage): 2.547991814236384
EBIT margin: 3.203851624904256%
Interest burden factor: 0.1915983606557377
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for CRRX.TO (quarterly period ending 2025-12-31)
ROE: 21.724320572764466%
Net margin: 24.759317659058503%
Asset turnover: 0.3954813189708044
Equity multiplier (leverage): 2.2186130187025133
EBIT margin: 3.1244470811086478%
Interest burden factor: 0.338107928047968
Tax burden factor: 23.437438423645318
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CRRX.TO (quarterly period ending 2026-03-31)
ROE: 1.055551449062424%
Net margin: 1.2446365639939097%
Asset turnover: 0.3792511418582841
Equity multiplier (leverage): 2.2361964517460713
EBIT margin: 3.6583158544765397%
Interest burden factor: 0.5046565774155994
Tax burden factor: 0.6741637831603229
ROE archetype: Low Return
DuPont ROE decomposition for CRS.L (annual period ending 2021-06-30)
ROE: 28.12058241505051%
Net margin: 96.88476656404636%
Asset turnover: 0.2798564143175758
Equity multiplier (leverage): 1.0371308401845742
Tax burden factor: 1
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CRS.L (annual period ending 2022-06-30)
ROE: 6.736524235318553%
Net margin: 88.38522826321076%
Asset turnover: 0.07465077845060215
Equity multiplier (leverage): 1.0209908448338219
Tax burden factor: 1
ROE archetype: Standard Business
DuPont ROE decomposition for CRS.L (annual period ending 2023-06-30)
ROE: -5.749346267490941%
Asset turnover: -0.04810831477562969
Equity multiplier (leverage): 1.0246093832953327
ROE archetype: Low Return
DuPont ROE decomposition for CRS.L (annual period ending 2024-06-30)
ROE: 56.058050786458104%
Net margin: 576.5918840194616%
Asset turnover: 0.09503377808963441
Equity multiplier (leverage): 1.0230373097438248
Tax burden factor: 1
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CRSR (annual period ending 2022-12-31)
ROE: -8.230576991733722%
Net margin: -3.923065846943272%
Asset turnover: 1.060014106818681
Equity multiplier (leverage): 1.9792152985655307
EBIT margin: -3.984661456856166%
ROE archetype: Low Return
DuPont ROE decomposition for CRSR (annual period ending 2023-12-31)
ROE: 0.4723531844193109%
Net margin: 0.21830636184604846%
Asset turnover: 1.0998384756440256
Equity multiplier (leverage): 1.9673043261741763
EBIT margin: 0.6636869594999573%
Interest burden factor: -0.3590669831767984
ROE archetype: Low Return
DuPont ROE decomposition for CRSR (annual period ending 2024-12-31)
ROE: -12.69863989913448%
Net margin: -6.335105619278339%
Asset turnover: 1.015218494485002
Equity multiplier (leverage): 1.974439483734217
EBIT margin: -3.794803776116149%
ROE archetype: Low Return
DuPont ROE decomposition for CRSR (annual period ending 2025-12-31)
ROE: -1.9704301117762641%
Net margin: -0.8465310224926654%
Asset turnover: 1.1828987075501294
Equity multiplier (leverage): 1.9677530773644767
EBIT margin: 0.14098663479300227%
Interest burden factor: -5.852119460500964
ROE archetype: Low Return
DuPont ROE decomposition for CRSU.PA (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 8.132824910350358
ROE archetype: Standard Business
DuPont ROE decomposition for CRSU.PA (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 7.946249072887318
ROE archetype: Standard Business
DuPont ROE decomposition for CRSU.PA (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 7.614751338889453
ROE archetype: Standard Business
DuPont ROE decomposition for CRT (annual period ending 2022-12-31)
ROE: 396.46908882815575%
Net margin: 93.99305747596374%
Asset turnover: 2.568630119665746
Equity multiplier (leverage): 1.6421468253231397
EBIT margin: 93.86928336116198%
Interest burden factor: 1.0013185795221804
Tax burden factor: 1
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CRT (annual period ending 2023-12-31)
ROE: 409.969294606693%
Net margin: 93.88392491294434%
Asset turnover: 2.6190285672308855
Equity multiplier (leverage): 1.6673234475386516
EBIT margin: 93.36444454128136%
Interest burden factor: 1.0055640064503708
Tax burden factor: 1
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CRT (annual period ending 2024-12-31)
ROE: 222.4446304521103%
Net margin: 86.51020687084929%
Asset turnover: 1.5746776682395025
Equity multiplier (leverage): 1.632912478474227
EBIT margin: 85.59216062586762%
Interest burden factor: 1.0107258215970798
Tax burden factor: 1
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CRT (annual period ending 2025-12-31)
ROE: 195.60430370550404%
Net margin: 78.2616969663172%
Asset turnover: 1.4162227478606997
Equity multiplier (leverage): 1.7648084701217224
EBIT margin: 77.39589142315414%
Interest burden factor: 1.0111867119461078
Tax burden factor: 1
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CRTM.L (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 7.0576170604989406
ROE archetype: Standard Business
DuPont ROE decomposition for CRTO (quarterly period ending 2025-03-31)
ROE: 3.636583423919958%
Net margin: 8.863089621074177%
Asset turnover: 0.21214552067840098
Equity multiplier (leverage): 1.9340805063640891
EBIT margin: 10.669776755849139%
Interest burden factor: 1.047792056802375
Tax burden factor: 0.7927836889972062
ROE archetype: Low Return
DuPont ROE decomposition for CRTO (quarterly period ending 2025-06-30)
ROE: 2.1380134397237955%
Net margin: 4.748576152285925%
Asset turnover: 0.23659350712710542
Equity multiplier (leverage): 1.9030237208730092
EBIT margin: 6.309680921372943%
Interest burden factor: 0.9408635692004598
Tax burden factor: 0.7998883227472604
ROE archetype: Low Return
DuPont ROE decomposition for CRTO (quarterly period ending 2025-09-30)
ROE: 3.4872899735953746%
Net margin: 8.533194225610016%
Asset turnover: 0.22491027604736205
Equity multiplier (leverage): 1.817051061558147
EBIT margin: 10.992845888515095%
Interest burden factor: 0.9995932518545778
Tax burden factor: 0.7765656487366299
ROE archetype: Low Return
DuPont ROE decomposition for CRTO (quarterly period ending 2025-12-31)
ROE: 4.043169460585419%
Net margin: 8.804071434907307%
Asset turnover: 0.253846318030779
Equity multiplier (leverage): 1.8091205966394897
EBIT margin: 13.400328198456583%
Interest burden factor: 1.004537054913534
Tax burden factor: 0.6540367639992861
ROE archetype: Low Return
DuPont ROE decomposition for CRTO (quarterly period ending 2026-03-31)
ROE: 0.720081523536501%
Net margin: 2.020539799688677%
Asset turnover: 0.19636258059644812
Equity multiplier (leverage): 1.8149118121302268
EBIT margin: 2.44913915113779%
Interest burden factor: 1.1800961538461539
Tax burden factor: 0.6990955756538744
ROE archetype: Low Return
DuPont ROE decomposition for CRWN.L (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 1.0103356661482634
ROE archetype: Standard Business
DuPont ROE decomposition for CRWN.L (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 1.0082097581567575
ROE archetype: Standard Business
DuPont ROE decomposition for CSAI (quarterly period ending 2024-12-31)
Net margin: -282.95454545454544%
Asset turnover: 0.7154471544715447
EBIT margin: -283.4090909090909%
ROE archetype: Standard Business
DuPont ROE decomposition for CSAI (quarterly period ending 2025-03-31)
ROE: -63.10512298292339%
Net margin: -273.27001356852105%
Asset turnover: 0.17113665389527458
Equity multiplier (leverage): 1.3493655021149928
EBIT margin: -330.80054274084125%
ROE archetype: Low Return
DuPont ROE decomposition for CSAI (quarterly period ending 2025-06-30)
ROE: -26.895029102829998%
Net margin: -184.40366972477065%
Asset turnover: 0.12778429073856976
Equity multiplier (leverage): 1.141366160433532
EBIT margin: -176.23853211009174%
ROE archetype: Low Return
DuPont ROE decomposition for CSAI (quarterly period ending 2025-09-30)
ROE: -27.765434592338252%
Net margin: -142.1607188285736%
Asset turnover: 0.16346097932044854
Equity multiplier (leverage): 1.194842792701811
EBIT margin: -136.71421214212486%
ROE archetype: Low Return
DuPont ROE decomposition for CSAI (quarterly period ending 2025-12-31)
ROE: -23.35859389925492%
Net margin: -102.57270693512304%
Asset turnover: 0.1901419684160153
Equity multiplier (leverage): 1.1976692351779914
EBIT margin: -101.06263982102908%
ROE archetype: Low Return
DuPont ROE decomposition for CSAI (quarterly period ending 2026-03-31)
ROE: -39.58898244612531%
Net margin: -210.9505703422053%
Asset turnover: 0.14695200312901605
Equity multiplier (leverage): 1.2770800627943486
EBIT margin: -204.25855513307988%
ROE archetype: Low Return
DuPont ROE decomposition for CSBBANK.NS (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 9.530797709582608
ROE archetype: Standard Business
DuPont ROE decomposition for CSBBANK.NS (quarterly period ending 2025-03-31)
ROE: 4.363647677292109%
Net margin: 25.29957222945506%
Asset turnover: 0.017076939308627363
Equity multiplier (leverage): 10.100118406776554
Tax burden factor: 0.7423403757698604
ROE archetype: Low Return
DuPont ROE decomposition for CSBBANK.NS (quarterly period ending 2025-06-30)
Net margin: 19.002755880279434%
Tax burden factor: 0.743480441323972
ROE archetype: Standard Business
DuPont ROE decomposition for CSBBANK.NS (quarterly period ending 2025-09-30)
ROE: 3.4110661257071397%
Net margin: 20.747709508773745%
Asset turnover: 0.015448865964954367
Equity multiplier (leverage): 10.64200294024412
Tax burden factor: 0.7434732204961743
ROE archetype: Low Return
DuPont ROE decomposition for CSBBANK.NS (quarterly period ending 2025-12-31)
Net margin: 20.923157043595054%
Tax burden factor: 0.7434985877081913
ROE archetype: Standard Business
DuPont ROE decomposition for CSBBANK.NS (quarterly period ending 2026-03-31)
ROE: 4.118685485914165%
Net margin: 26.16664719550346%
Asset turnover: 0.013345166138544293
Equity multiplier (leverage): 11.794690945348435
Tax burden factor: 0.7447995566229448
ROE archetype: Low Return
DuPont ROE decomposition for CSBBANK.NS (quarterly period ending 2026-06-30)
Net margin: 21.209765199813404%
Tax burden factor: 0.7437295528898582
ROE archetype: Standard Business
DuPont ROE decomposition for CSBR (quarterly period ending 2025-01-31)
ROE: 82.19052843298591%
Net margin: 26.380656141792358%
Asset turnover: 0.5563391778496098
Equity multiplier (leverage): 5.600109709270433
EBIT margin: 26.404131697869595%
Interest burden factor: 1.0042231607023784
Tax burden factor: 0.9949092518813635
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CSBR (quarterly period ending 2025-04-30)
ROE: -39.7143166323991%
Net margin: -12.06681133688433%
Asset turnover: 0.4829842308364168
Equity multiplier (leverage): 6.814305811059409
EBIT margin: -11.271125139738277%
ROE archetype: Low Return
DuPont ROE decomposition for CSBR (quarterly period ending 2025-07-31)
ROE: -12.749658002735979%
Net margin: -3.329760628795998%
Asset turnover: 0.4450628080775958
Equity multiplier (leverage): 8.60328317373461
EBIT margin: -3.622722400857449%
ROE archetype: Low Return
DuPont ROE decomposition for CSBR (quarterly period ending 2025-10-31)
ROE: 7.697258334405972%
Net margin: 1.9886930495510478%
Asset turnover: 0.49532186861698624
Equity multiplier (leverage): 7.81413309306217
EBIT margin: 1.2304622547389426%
Interest burden factor: 1.3783783783783783
Tax burden factor: 1.1725490196078432
ROE archetype: Standard Business
DuPont ROE decomposition for CSBR (quarterly period ending 2026-01-31)
ROE: -6.481589034731096%
Net margin: -1.6848843529198625%
Asset turnover: 0.5650667986145472
Equity multiplier (leverage): 6.807875479149727
EBIT margin: -1.1292952472975422%
ROE archetype: Low Return
DuPont ROE decomposition for CSIQ (annual period ending 2022-12-31)
ROE: 12.942982467548791%
Net margin: 3.997464052882665%
Asset turnover: 0.8264362306254819
Equity multiplier (leverage): 3.917783633199721
EBIT margin: 4.767433297494446%
Interest burden factor: 1.0011430625651223
Tax burden factor: 0.8375366091767004
ROE archetype: Standard Business
DuPont ROE decomposition for CSIQ (annual period ending 2023-12-31)
ROE: 12.235136133494203%
Net margin: 4.7760948594007635%
Asset turnover: 0.7367874196763612
Equity multiplier (leverage): 3.476911689674295
EBIT margin: 5.954061835976708%
Interest burden factor: 0.9011845936645195
Tax burden factor: 0.890114436081023
ROE archetype: Standard Business
DuPont ROE decomposition for CSIQ (annual period ending 2024-12-31)
ROE: 0.883189775763397%
Net margin: 0.601510759569387%
Asset turnover: 0.4540698144991651
Equity multiplier (leverage): 3.2336126906644815
EBIT margin: -0.5019013386204746%
ROE archetype: Low Return
DuPont ROE decomposition for CSIQ (annual period ending 2025-12-31)
ROE: -2.525701451347464%
Net margin: -1.861018922426327%
Asset turnover: 0.3979965285110333
Equity multiplier (leverage): 3.4099808561305918
EBIT margin: 0.7713167951926567%
Interest burden factor: -3.2611687830197424
ROE archetype: Low Return
DuPont ROE decomposition for CSL.AX (annual period ending 2022-06-30)
ROE: 15.466986794717888%
Net margin: 21.487453660024205%
Asset turnover: 0.3701792139984478
Equity multiplier (leverage): 1.9445035156919912
EBIT margin: 22.07260008958268%
Interest burden factor: 1.200120892880273
Tax burden factor: 0.8111598791192978
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CSL.AX (annual period ending 2023-06-30)
ROE: 13.597236507313823%
Net margin: 17.033550933657203%
Asset turnover: 0.40071213285762713
Equity multiplier (leverage): 1.9921083959425174
EBIT margin: 15.955670259602247%
Interest burden factor: 1.2668886774500474
Tax burden factor: 0.842658655651521
ROE archetype: Standard Business
DuPont ROE decomposition for CSL.AX (annual period ending 2024-06-30)
ROE: 14.627200273545713%
Net margin: 18.47515316541865%
Asset turnover: 0.39694098880661455
Equity multiplier (leverage): 1.9945604949521285
EBIT margin: 18.815520762423414%
Interest burden factor: 1.2210564399421129
Tax burden factor: 0.8041481481481482
ROE archetype: Standard Business
DuPont ROE decomposition for CSL.AX (annual period ending 2025-06-30)
ROE: 15.224771713383964%
Net margin: 20.32404406999352%
Asset turnover: 0.3946975971792551
Equity multiplier (leverage): 1.8979124682432915
EBIT margin: 19.17692806221646%
Interest burden factor: 1.2585332882730653
Tax burden factor: 0.8421052631578948
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CSX.AX (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 1.4392114082268115
ROE archetype: Standard Business
DuPont ROE decomposition for CTHT.L (annual period ending 2022-11-30)
ROE: -4.124557165701177%
Asset turnover: -0.03667032092718
Equity multiplier (leverage): 1.0862648183956205
ROE archetype: Low Return
DuPont ROE decomposition for CTHT.L (annual period ending 2023-11-30)
ROE: -15.035013529556048%
Asset turnover: -0.13004594984520415
Equity multiplier (leverage): 1.139090443370139
ROE archetype: Low Return
DuPont ROE decomposition for CTHT.L (annual period ending 2024-11-30)
ROE: 13.371695001165179%
Net margin: 98.30282506966017%
Asset turnover: 0.10001680125449366
Equity multiplier (leverage): 1.3600269124086335
Tax burden factor: 0.998469809200103
ROE archetype: Standard Business
DuPont ROE decomposition for CTHT.L (annual period ending 2025-11-30)
ROE: -18.765715199137066%
Asset turnover: -0.12616495506538458
Equity multiplier (leverage): 1.4430843736997745
ROE archetype: Low Return
DuPont ROE decomposition for CTO.DE (quarterly period ending 2025-02-28)
ROE: 6.990655667201001%
Net margin: 2.8058942610988185%
Asset turnover: 0.8702474598492298
Equity multiplier (leverage): 2.86288462290339
EBIT margin: 3.634480485852832%
Interest burden factor: 1.045768566493955
Tax burden factor: 0.7382328654004955
ROE archetype: Standard Business
DuPont ROE decomposition for CTO.DE (quarterly period ending 2025-05-31)
ROE: 7.2217373154718985%
Net margin: 3.010837750177992%
Asset turnover: 0.850066574314419
Equity multiplier (leverage): 2.821638647489659
EBIT margin: 4.002847875959181%
Interest burden factor: 1.0197628458498025
Tax burden factor: 0.7375968992248062
ROE archetype: Standard Business
DuPont ROE decomposition for CTO.DE (quarterly period ending 2025-08-31)
ROE: 9.273570324574962%
Net margin: 3.0293885510005105%
Asset turnover: 1.12931492125494
Equity multiplier (leverage): 2.710671712057418
EBIT margin: 3.87784948233437%
Interest burden factor: 1.0505836575875487
Tax burden factor: 0.7435897435897436
ROE archetype: Standard Business
DuPont ROE decomposition for CTO.DE (quarterly period ending 2025-11-30)
ROE: 6.7297829048043445%
Net margin: 2.9729448645757497%
Asset turnover: 0.8419215830982745
Equity multiplier (leverage): 2.6887012965173964
EBIT margin: 3.659351924762655%
Interest burden factor: 1.048721071863581
Tax burden factor: 0.7746806039488966
ROE archetype: Standard Business
DuPont ROE decomposition for CTO.DE (quarterly period ending 2026-02-28)
ROE: 6.523481327135759%
Net margin: 2.923976608187134%
Asset turnover: 0.8363566445751642
Equity multiplier (leverage): 2.66755890367046
EBIT margin: 3.74441427073006%
Interest burden factor: 1.0441289332310053
Tax burden factor: 0.7478868063212054
ROE archetype: Standard Business
DuPont ROE decomposition for CTO.DE (quarterly period ending 2026-05-31)
ROE: 6.683334349655466%
Net margin: 3.1080295489670626%
Asset turnover: 0.829392775873322
Equity multiplier (leverage): 2.592673333739862
EBIT margin: 3.991379188112354%
Interest burden factor: 1.0436944937833037
Tax burden factor: 0.7460857726344452
ROE archetype: Standard Business
DuPont ROE decomposition for CTP.AX (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 2.7872387238723872
ROE archetype: Standard Business
DuPont ROE decomposition for CTSO (annual period ending 2022-12-31)
ROE: -92.75648917103061%
Net margin: -111.75982147084238%
Asset turnover: 0.4643238903123173
Equity multiplier (leverage): 1.787465109867363
EBIT margin: -107.36367720473257%
ROE archetype: Low Return
DuPont ROE decomposition for CTSO (annual period ending 2023-12-31)
ROE: -99.38380819674913%
Net margin: -94.0865504927738%
Asset turnover: 0.5350809480495431
Equity multiplier (leverage): 1.9740975065204276
EBIT margin: -102.77840857600782%
ROE archetype: Low Return
DuPont ROE decomposition for CTSO (annual period ending 2024-12-31)
ROE: -119.80381525336925%
Net margin: -58.20761342885237%
Asset turnover: 0.7095703245191323
Equity multiplier (leverage): 2.9006505510807816
EBIT margin: -46.21997471554994%
ROE archetype: Low Return
DuPont ROE decomposition for CTSO (annual period ending 2025-12-31)
ROE: -96.39035861258084%
Net margin: -22.119094514745164%
Asset turnover: 0.8096423968368395
Equity multiplier (leverage): 5.382363315696649
EBIT margin: -38.41836872352481%
ROE archetype: Low Return
DuPont ROE decomposition for CTUK.L (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 1.0831555201544214
ROE archetype: Standard Business
DuPont ROE decomposition for CTUK.L (quarterly period ending 2025-03-31)
Equity multiplier (leverage): 1.075628083702625
ROE archetype: Standard Business
DuPont ROE decomposition for CTUK.L (quarterly period ending 2025-09-30)
Equity multiplier (leverage): 1.056493253987702
ROE archetype: Standard Business
DuPont ROE decomposition for CTUK.L (quarterly period ending 2026-03-31)
Equity multiplier (leverage): 1.0588552120439858
ROE archetype: Standard Business
DuPont ROE decomposition for CTY.L (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 1.0801217641815917
ROE archetype: Standard Business
DuPont ROE decomposition for CTY.L (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 1.0686929108865655
ROE archetype: Standard Business
DuPont ROE decomposition for CTY.L (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 1.0611573919111812
ROE archetype: Standard Business
DuPont ROE decomposition for CTZ.V (annual period ending 2022-10-31)
ROE: 23.061372185051948%
Net margin: 25.84794452267849%
Asset turnover: 0.8044638146583283
Equity multiplier (leverage): 1.1090538096479239
EBIT margin: 32.544472148174314%
Interest burden factor: 1.0814368945089232
Tax burden factor: 0.7344252486725001
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CTZ.V (annual period ending 2023-10-31)
ROE: 23.260483001261093%
Net margin: 26.50368782639807%
Asset turnover: 0.791548811902839
Equity multiplier (leverage): 1.108752774560038
EBIT margin: 34.96522250050057%
Interest burden factor: 1.078072208625644
Tax burden factor: 0.7031081964814875
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CTZ.V (annual period ending 2024-10-31)
ROE: 26.017856918032017%
Net margin: 30.56184765646815%
Asset turnover: 0.7647146691709072
Equity multiplier (leverage): 1.1132494604879801
EBIT margin: 37.60179972766664%
Interest burden factor: 1.1234167101474406
Tax burden factor: 0.7234859391828473
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CTZ.V (annual period ending 2025-10-31)
ROE: 26.01768006177257%
Net margin: 31.503211323932206%
Asset turnover: 0.7538173329027474
Equity multiplier (leverage): 1.0955888992687652
EBIT margin: 40.52161759236556%
Interest burden factor: 1.063636130521989
Tax burden factor: 0.7309286267435235
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CURN.SW (annual period ending 2022-12-31)
ROE: -514.319561676292%
Asset turnover: 0
Equity multiplier (leverage): 2.0799644602398932
ROE archetype: Low Return
DuPont ROE decomposition for CURN.SW (annual period ending 2023-12-31)
ROE: -1687.1142405133805%
Asset turnover: 0
Equity multiplier (leverage): 2.2113237817241918
ROE archetype: Low Return
DuPont ROE decomposition for CURN.SW (annual period ending 2024-12-31)
ROE: -19.19860121320768%
Net margin: -63.007540603248266%
Asset turnover: 0.24776980485150854
Equity multiplier (leverage): 1.2297835541556468
EBIT margin: -47.18677494199536%
ROE archetype: Low Return
DuPont ROE decomposition for CURN.SW (annual period ending 2025-12-31)
ROE: -3.2890110023405557%
Net margin: -13.111111111111109%
Asset turnover: 0.20629334786725154
Equity multiplier (leverage): 1.2160196824493943
EBIT margin: -14.305555555555555%
ROE archetype: Low Return
DuPont ROE decomposition for CVBF (quarterly period ending 2025-03-31)
ROE: 2.2932850599460872%
Net margin: 40.343245995594955%
Asset turnover: 0.008302837770246315
Equity multiplier (leverage): 6.8463744924091925
Tax burden factor: 0.7350026607602583
ROE archetype: Low Return
DuPont ROE decomposition for CVBF (quarterly period ending 2025-06-30)
ROE: 2.263008753472175%
Net margin: 40.01836140306445%
Asset turnover: 0.008239258542373359
Equity multiplier (leverage): 6.863391948649519
Tax burden factor: 0.7349952758194637
ROE archetype: Low Return
DuPont ROE decomposition for CVBF (quarterly period ending 2025-09-30)
ROE: 2.325584995010381%
Net margin: 40.89654153348421%
Asset turnover: 0.008274234873136506
Equity multiplier (leverage): 6.872548115608808
Tax burden factor: 0.7620386337617923
ROE archetype: Low Return
DuPont ROE decomposition for CVBF (quarterly period ending 2025-12-31)
ROE: 2.405090696658788%
Net margin: 41.123338637738975%
Asset turnover: 0.008553528328038941
Equity multiplier (leverage): 6.837507163079647
Tax burden factor: 0.7402167773862994
ROE archetype: Low Return
DuPont ROE decomposition for CVBF (quarterly period ending 2026-03-31)
ROE: 2.2095502983317465%
Net margin: 38.60307752859165%
Asset turnover: 0.00848585715095916
Equity multiplier (leverage): 6.74506666839958
Tax burden factor: 0.7440008169100378
ROE archetype: Low Return
DuPont ROE decomposition for CVCG.L (annual period ending 2022-12-31)
ROE: -14.2596468564076%
Asset turnover: -0.07758824174020519
Equity multiplier (leverage): 1.001593170417364
ROE archetype: Low Return
DuPont ROE decomposition for CVCG.L (annual period ending 2023-12-31)
ROE: 13.354369748104858%
Net margin: 61.049033893896464%
Asset turnover: 0.21851653202422275
Equity multiplier (leverage): 1.0010604453914436
Tax burden factor: 1
ROE archetype: Standard Business
DuPont ROE decomposition for CVCG.L (annual period ending 2024-12-31)
ROE: 7.882593646582088%
Net margin: 47.00231031406547%
Asset turnover: 0.16759824299752338
Equity multiplier (leverage): 1.0006460194391884
Tax burden factor: 1
ROE archetype: Standard Business
DuPont ROE decomposition for CVCG.L (annual period ending 2025-12-31)
ROE: -2.265155516382569%
Net margin: -35.04323689548414%
Asset turnover: 0.06457974645537891
Equity multiplier (leverage): 1.0009156369309369
ROE archetype: Low Return
DuPont ROE decomposition for CVCO (annual period ending 2023-03-31)
ROE: 24.63833944583404%
Net margin: 11.240002744184592%
Asset turnover: 1.6381910969246354
Equity multiplier (leverage): 1.3380749970588386
EBIT margin: 13.842684484576328%
Interest burden factor: 1.0342336206925615
Tax burden factor: 0.7851044617506022
ROE archetype: Asset-Light Turnover Play
DuPont ROE decomposition for CVCO (annual period ending 2024-03-31)
ROE: 15.704783292787964%
Net margin: 8.79795541767514%
Asset turnover: 1.3483854124602996
Equity multiplier (leverage): 1.3238419705248752
EBIT margin: 9.97229762557444%
Interest burden factor: 1.1128493368048185
Tax burden factor: 0.7927753790541219
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CVCO (annual period ending 2025-03-31)
ROE: 16.304725516243384%
Net margin: 8.486210082274104%
Asset turnover: 1.4600509633965455
Equity multiplier (leverage): 1.3159266975628612
EBIT margin: 9.440831810933297%
Interest burden factor: 1.1092833568080052
Tax burden factor: 0.8103283270952765
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CVCO (annual period ending 2026-03-31)
ROE: 17.580419270732424%
Net margin: 8.489666986707537%
Asset turnover: 1.5491182227522824
Equity multiplier (leverage): 1.3367617508178935
EBIT margin: 10.183492574086491%
Interest burden factor: 1.0705738748474203
Tax burden factor: 0.7787127094401308
ROE archetype: Asset-Light Turnover Play
DuPont ROE decomposition for CVO.TO (quarterly period ending 2024-12-31)
ROE: 3.1404342558941387%
Net margin: 11.906374208744296%
Asset turnover: 0.14904905256321366
Equity multiplier (leverage): 1.769623831267667
EBIT margin: -15.892830855292214%
Tax burden factor: 1.8381818181818181
ROE archetype: Low Return
DuPont ROE decomposition for CVO.TO (quarterly period ending 2025-03-31)
ROE: -4.940570011616129%
Net margin: -18.387190684133916%
Asset turnover: 0.14992242005774303
Equity multiplier (leverage): 1.7922355766410225
EBIT margin: -22.014556040756915%
ROE archetype: Low Return
DuPont ROE decomposition for CVO.TO (quarterly period ending 2025-06-30)
ROE: -12.348320892520142%
Net margin: -42.34632156421438%
Asset turnover: 0.16036776082175597
Equity multiplier (leverage): 1.818340242813931
EBIT margin: -30.592207061471377%
ROE archetype: Low Return
DuPont ROE decomposition for CVO.TO (quarterly period ending 2025-12-31)
ROE: -6.5691229288710575%
Net margin: -18.906336305531447%
Asset turnover: 0.17364198757253355
Equity multiplier (leverage): 2.0009915829685343
EBIT margin: -16.470712012414843%
ROE archetype: Low Return
DuPont ROE decomposition for CVO.TO (quarterly period ending 2026-03-31)
ROE: -2.3681628564661295%
Net margin: -6.009936428228004%
Asset turnover: 0.17356108125550804
Equity multiplier (leverage): 2.270331840116702
EBIT margin: -9.690688605160531%
ROE archetype: Low Return
DuPont ROE decomposition for CWAN (quarterly period ending 2025-03-31)
ROE: 0.6070328643181777%
Net margin: 5.467272039349225%
Asset turnover: 0.09870211511201084
Equity multiplier (leverage): 1.1249029631360563
EBIT margin: 5.582355908689621%
Interest burden factor: 1.198249082180175
Tax burden factor: 0.8173462172990809
ROE archetype: Low Return
DuPont ROE decomposition for CWAN (quarterly period ending 2025-06-30)
ROE: -1.4837520367651074%
Net margin: -12.76540780599878%
Asset turnover: 0.08449325387288419
Equity multiplier (leverage): 1.3756393789387706
EBIT margin: -8.01376300587566%
ROE archetype: Low Return
DuPont ROE decomposition for CWAN (quarterly period ending 2025-09-30)
ROE: -0.5181073116296417%
Net margin: -5.038759689922481%
Asset turnover: 0.06823654069914925
Equity multiplier (leverage): 1.5068814025543418
EBIT margin: 3.1953585880746918%
Interest burden factor: -1.526396093988404
ROE archetype: Low Return
DuPont ROE decomposition for CWAN (quarterly period ending 2025-12-31)
ROE: -0.5984164727698434%
Net margin: -5.548683187940604%
Asset turnover: 0.07221556840490426
Equity multiplier (leverage): 1.4934227998858316
EBIT margin: -3.100842925267984%
ROE archetype: Low Return
DuPont ROE decomposition for CWAN (quarterly period ending 2026-03-31)
ROE: -0.13589011698004774%
Net margin: -1.254814038006039%
Asset turnover: 0.07302719489587349
Equity multiplier (leverage): 1.4829410419971931
EBIT margin: 4.063680908384111%
Interest burden factor: -0.40100111234705227
ROE archetype: Low Return
DuPont ROE decomposition for CWST (annual period ending 2022-12-31)
ROE: 10.660574412532638%
Net margin: 4.891672480321891%
Asset turnover: 0.7487425951290871
Equity multiplier (leverage): 2.910654749949789
EBIT margin: 9.348818391855415%
Interest burden factor: 0.7389962836272587
Tax burden factor: 0.7080409785769549
ROE archetype: Standard Business
DuPont ROE decomposition for CWST (annual period ending 2023-12-31)
ROE: 3.342653210422382%
Net margin: 2.008553294394334%
Asset turnover: 0.6347011118821186
Equity multiplier (leverage): 2.6220363218575353
EBIT margin: 8.072646064741226%
Interest burden factor: 0.3628945357653651
Tax burden factor: 0.685625590498043
ROE archetype: Low Return
DuPont ROE decomposition for CWST (annual period ending 2024-12-31)
ROE: 1.052308338159782%
Net margin: 0.8692061751139645%
Asset turnover: 0.5402038803664116
Equity multiplier (leverage): 2.2411065718739187
EBIT margin: 6.80833220423006%
Interest burden factor: 0.1985192171657628
Tax burden factor: 0.6431014823261118
ROE archetype: Low Return
DuPont ROE decomposition for CWST (annual period ending 2025-12-31)
ROE: 0.5046243878920921%
Net margin: 0.42850742116492385%
Asset turnover: 0.5622930440135709
Equity multiplier (leverage): 2.0943399492490578
EBIT margin: 4.855183437216395%
Interest burden factor: 0.1463524029512682
Tax burden factor: 0.6030493410971499
ROE archetype: Low Return
DuPont ROE decomposition for CX (quarterly period ending 2025-03-31)
ROE: 5.553312775598115%
Net margin: 20.531267293857223%
Asset turnover: 0.12918739271172916
Equity multiplier (leverage): 2.093708635491177
EBIT margin: 8.024349750968456%
Interest burden factor: 0.6068965517241379
Tax burden factor: 4.215909090909091
ROE archetype: Standard Business
DuPont ROE decomposition for CX (quarterly period ending 2025-06-30)
ROE: 2.4479029922893063%
Net margin: 7.770683019037585%
Asset turnover: 0.14988780418651057
Equity multiplier (leverage): 2.1016902632103753
EBIT margin: 12.08348564313179%
Interest burden factor: 0.8797765918939742
Tax burden factor: 0.7309615968078554
ROE archetype: Low Return
DuPont ROE decomposition for CX (quarterly period ending 2025-09-30)
ROE: 1.9963117082312372%
Net margin: 6.408057057238846%
Asset turnover: 0.14860886265302545
Equity multiplier (leverage): 2.0963185310417245
EBIT margin: 12.89221964087896%
Interest burden factor: 0.6591592990687503
Tax burden factor: 0.7540641448872848
ROE archetype: Low Return
DuPont ROE decomposition for CX (quarterly period ending 2025-12-31)
ROE: -2.6088017360041564%
Net margin: -8.509351468063855%
Asset turnover: 0.1457596786780909
Equity multiplier (leverage): 2.1033290036637435
EBIT margin: 10.931510290502592%
Interest burden factor: -0.39984417335276784
ROE archetype: Low Return
DuPont ROE decomposition for CX (quarterly period ending 2026-03-31)
ROE: 1.720438866235645%
Net margin: 5.82234386663349%
Asset turnover: 0.14027292819384796
Equity multiplier (leverage): 2.1065294296776154
EBIT margin: 11.271460562328937%
Interest burden factor: 0.7174392935982341
Tax burden factor: 0.72
ROE archetype: Low Return
DuPont ROE decomposition for CX (quarterly period ending 2026-06-30)
ROE: 2.757456416338246%
Net margin: 7.738685109295567%
Asset turnover: 0.16603339292367356
Equity multiplier (leverage): 2.146080648901243
EBIT margin: 14.817817502268465%
Interest burden factor: 0.7278606731272148
Tax burden factor: 0.7175211035618694
ROE archetype: Low Return
DuPont ROE decomposition for CXT (annual period ending 2022-12-31)
ROE: 26.141872926767036%
Net margin: 15.292185984028658%
Asset turnover: 0.629238283084437
Equity multiplier (leverage): 2.716764480734881
EBIT margin: 22.949473841331443%
Interest burden factor: 0.807479674796748
Tax burden factor: 0.8252114377768828
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CXT (annual period ending 2023-12-31)
ROE: 21.547087767479116%
Net margin: 13.53410479407748%
Asset turnover: 0.6533765379919226
Equity multiplier (leverage): 2.436663233779609
EBIT margin: 20.649752030475096%
Interest burden factor: 0.8346675948485903
Tax burden factor: 0.7852376980817348
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CXT (annual period ending 2024-12-31)
ROE: 18.14776479865937%
Net margin: 12.382297551789078%
Asset turnover: 0.658473394007839
Equity multiplier (leverage): 2.2257873724678396
EBIT margin: 18.75840731772935%
Interest burden factor: 0.8117604876299749
Tax burden factor: 0.8131625441696113
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CXT (annual period ending 2025-12-31)
ROE: 12.499461601412758%
Net margin: 8.758375082996318%
Asset turnover: 0.6021188827709026
Equity multiplier (leverage): 2.370202868587673
EBIT margin: 15.905112573187663%
Interest burden factor: 0.6869070208728653
Tax burden factor: 0.8016574585635359
ROE archetype: Standard Business
DuPont ROE decomposition for CY5.AX (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 1.1036570444321874
ROE archetype: Standard Business
DuPont ROE decomposition for CY5.AX (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 1.0907135179527732
ROE archetype: Standard Business
DuPont ROE decomposition for CYAD.BR (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 19.428571428571384
ROE archetype: Standard Business
DuPont ROE decomposition for CYB.AX (annual period ending 2022-06-30)
ROE: -40.98659299862815%
Net margin: -365.8801393685514%
Asset turnover: 0.09224674946572896
Equity multiplier (leverage): 1.2143724658083492
EBIT margin: -369.587983057212%
ROE archetype: Low Return
DuPont ROE decomposition for CYB.AX (annual period ending 2023-06-30)
ROE: -66.15822827436055%
Net margin: -328.57160059392754%
Asset turnover: 0.15830983216590766
Equity multiplier (leverage): 1.2718794616810443
EBIT margin: -329.9023181266768%
ROE archetype: Low Return
DuPont ROE decomposition for CYB.AX (annual period ending 2024-06-30)
ROE: -58.438820210942765%
Net margin: -192.7455019598007%
Asset turnover: 0.2285480077225151
Equity multiplier (leverage): 1.3265992514897444
EBIT margin: -196.96603813717962%
ROE archetype: Low Return
DuPont ROE decomposition for CYB.AX (annual period ending 2025-06-30)
ROE: -145.92186776091575%
Net margin: -167.12867809833335%
Asset turnover: 0.6097107028623753
Equity multiplier (leverage): 1.432008457800293
EBIT margin: -50.19863523303209%
ROE archetype: Low Return
DuPont ROE decomposition for CYCN (quarterly period ending 2025-03-31)
ROE: -16.275626423690206%
Net margin: -1764.1975308641975%
Asset turnover: 0.008225855590535189
Equity multiplier (leverage): 1.1215261958997722
EBIT margin: -1798.7654320987656%
ROE archetype: Low Return
DuPont ROE decomposition for CYCN (quarterly period ending 2025-06-30)
ROE: -3.734870317002882%
Net margin: -348.38709677419354%
Asset turnover: 0.009678930113961596
Equity multiplier (leverage): 1.1076080691642651
EBIT margin: -1797.8494623655913%
ROE archetype: Low Return
DuPont ROE decomposition for CYCN (quarterly period ending 2025-09-30)
ROE: -10.779765849348353%
Net margin: -1063.8957704801844%
Asset turnover: 0.009273521354561536
Equity multiplier (leverage): 1.0926110006626906
EBIT margin: -1096.5974847367474%
ROE archetype: Low Return
DuPont ROE decomposition for CYCN (quarterly period ending 2025-12-31)
ROE: -8.580787198625355%
Net margin: -708.1867989371702%
Asset turnover: 0.011061111764705882
Equity multiplier (leverage): 1.095419642377705
EBIT margin: -742.7541145298483%
ROE archetype: Low Return
DuPont ROE decomposition for CYCN (quarterly period ending 2026-03-31)
ROE: -40.022675736961446%
Asset turnover: 0
Equity multiplier (leverage): 1.1646510456034265
ROE archetype: Low Return
DuPont ROE decomposition for CYCU (quarterly period ending 2025-03-31)
ROE: -109.02326889620451%
Net margin: -264.8153383031227%
Asset turnover: 0.12275300280257027
Equity multiplier (leverage): 3.3538523451550453
EBIT margin: 8.795467758814485%
Interest burden factor: -30.108158606770488
ROE archetype: Low Return
DuPont ROE decomposition for CYCU (quarterly period ending 2025-06-30)
ROE: -52.28194670727836%
Net margin: -133.45855040555156%
Asset turnover: 0.1248857156687749
Equity multiplier (leverage): 3.1368415346428082
EBIT margin: -96.86623807362044%
ROE archetype: Low Return
DuPont ROE decomposition for CYCU (quarterly period ending 2025-09-30)
ROE: -24.15656101170991%
Net margin: -81.48411260206656%
Asset turnover: 0.12159551208198685
Equity multiplier (leverage): 2.4380612997726048
EBIT margin: -118.21226400573121%
ROE archetype: Low Return
DuPont ROE decomposition for CYCU (quarterly period ending 2025-12-31)
ROE: -32.256396253856636%
Net margin: -144.10564538802092%
Asset turnover: 0.10774199952750553
Equity multiplier (leverage): 2.077542034994034
EBIT margin: -123.92329006245053%
ROE archetype: Low Return
DuPont ROE decomposition for CYCU (quarterly period ending 2026-03-31)
ROE: -14.225161153702887%
Net margin: -65.11806205677013%
Asset turnover: 0.10073026995738235
Equity multiplier (leverage): 2.1686812766168897
EBIT margin: -72.54345870734439%
ROE archetype: Low Return
DuPont ROE decomposition for CYD (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 2.1991098059159
ROE archetype: Standard Business
DuPont ROE decomposition for CYD (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 2.4782448209736967
ROE archetype: Standard Business
DuPont ROE decomposition for CYM.V (annual period ending 2022-04-30)
ROE: -202.6176021364278%
Net margin: -151.93967386833285%
Asset turnover: 0.5061848159770146
Equity multiplier (leverage): 2.6344919025937825
EBIT margin: -138.84936809228563%
ROE archetype: Low Return
DuPont ROE decomposition for CYM.V (annual period ending 2023-04-30)
ROE: -644.4309339833272%
Net margin: -198.07100145217737%
Asset turnover: 0.5700057387314318
Equity multiplier (leverage): 5.707898658222073
EBIT margin: -182.0675743921586%
ROE archetype: Low Return
DuPont ROE decomposition for CYM.V (annual period ending 2024-04-30)
Net margin: -263.4230224684898%
Asset turnover: 0.3975153138904451
EBIT margin: -238.26645187542024%
ROE archetype: Standard Business
DuPont ROE decomposition for CYM.V (annual period ending 2025-04-30)
Net margin: -90.79025131681603%
Asset turnover: 1.0991537395035222
EBIT margin: -66.01295458618492%
ROE archetype: Standard Business
DuPont ROE decomposition for CYPH (quarterly period ending 2025-03-31)
ROE: -74.06429942418427%
Asset turnover: 0
Equity multiplier (leverage): 1.6736564299424184
ROE archetype: Low Return
DuPont ROE decomposition for CYPH (quarterly period ending 2025-06-30)
ROE: -125.33795232895282%
Asset turnover: 0
Equity multiplier (leverage): 2.068042324057687
ROE archetype: Low Return
DuPont ROE decomposition for CYPH (quarterly period ending 2025-09-30)
ROE: -78.53067047075606%
Asset turnover: 0
Equity multiplier (leverage): 3.7376367094626723
ROE archetype: Low Return
DuPont ROE decomposition for CYPH (quarterly period ending 2025-12-31)
ROE: 51.475982868227476%
Asset turnover: 0
Equity multiplier (leverage): 1.1176689009673433
Tax burden factor: 0.8883462966236522
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CYPH (quarterly period ending 2026-03-31)
ROE: -64.8778170597904%
Asset turnover: 0
Equity multiplier (leverage): 1.0532997591232591
ROE archetype: Low Return
DuPont ROE decomposition for CYQ.AX (annual period ending 2021-06-30)
ROE: -311.14577369992725%
Net margin: -94.90437875316749%
Asset turnover: 0.9860783417215214
Equity multiplier (leverage): 3.3248054339248965
EBIT margin: -105.98666254904059%
ROE archetype: Low Return
DuPont ROE decomposition for CYQ.AX (annual period ending 2022-06-30)
ROE: -69.65873218446603%
Net margin: -17.137471812052336%
Asset turnover: 1.492436675832077
Equity multiplier (leverage): 2.7235346150129636
EBIT margin: -22.150996913471143%
ROE archetype: Low Return